LES INHIBITEURS IMMUNOLOGIQUES DE LA COAGULATION.SULTAN Y.1978; GAZ. MED. FR.; FR.; DA. 1978; VOL. 85; NO 10; PP. 1017-1026 (5P.); BIBL. 18 REF.Article

HEMOPHIBIE DONNEES RECENTES CONCERNANT LE DIAGNOSTIC ET LE TRAITEMENTSULTAN Y.1972; CONCOURS MED.; FR.; DA. 1972; VOL. 94; NO 34-35; PP. 5505-5509; BIBL. 11 REF.Serial Issue

METHODOLOGIE POUR L'ETUDE D'UN INHIBITEUR DE LA COAGULATIONSULTAN Y.1977; ACTUAL. HEMATOL.; FRA; DA. 1977; VOL. 11; PP. 105-108; BIBL. 6 REF.Article

ANTITHROMBINE III. PROPRIETES. INTERET EN CLINIQUE.SULTAN Y.1976; ACTUAL. HEMATOL.; FR.; DA. 1976; VOL. 10; PP. 170-174; BIBL. 9 REF.Article

Prevalence of inhibitors in a population of 3435 hemophilia patients in FranceSULTAN, Y.Thrombosis and haemostasis. 1992, Vol 67, Num 6, pp 600-602, issn 0340-6245Article

LOCALIZATION OF FACTOR VIII/VON WILLEBRAND FACTOR ANTIGEN BY IMMUNOELECTRON MICROSCOPY IN HUMAN ENDOTHELIAL CELLS USING FAB FRAGMENTS COUPLED TO PEROXIDASEJEANNEAU C; SULTAN Y.1982; J. HISTOCHEM. CYTOCHEM.; ISSN 0022-1554; USA; DA. 1982; VOL. 30; NO 11; PP. 1091-1096; BIBL. 21 REF.Article

Anticoagulants de type lupique et thromboses = Circulating anticoagulant factor in lupus and thrombosisSULTAN, Y.Annales de médecine interne (Paris). 1986, Vol 137, Num 6, pp 475-476, issn 0003-410XArticle

ACTION DU PHOSPHALUGEL SUR LE SYSTEME FIBRINOLYTIQUE DU PLASMA HUMAIN.SULTAN Y; BUNJEVACKI G.1978; GAZ. MED. FR.; FR.; DA. 1978; VOL. 85; NO 14; PP. 1517-1519; BIBL. 3 REF.Article

INCIDENCE DES INHIBITEURS DU FACTEUR VIII DANS LA POPULATION DES HEMOPHILES FRANCAIS.SULTAN Y; MAISONNEUVE P.1977; NOUV. REV. FR. HEMATOL.; FR.; DA. 1977; VOL. 18; NO 3; PP. 671-673Article

Le génie génétique au secours des maladies qui saignent et qui thrombosent = Genetic engineering for patients with bleeding disorders and thrombotic diseasesSULTAN, Y.MS. Médecine sciences. 1992, Vol 8, Num 10, pp 1034-1035, issn 0767-0974Article

LE FACTEUR WILLEBRAND.SULTAN Y; MAISONNEUVE P.1978; ACTUAL. HEMATOL.; FRA; DA. 1978; VOL. 12; PP. 237-242; BIBL. 11 REF.Article

LES INHIBITEURS ACQUIS DE LA PHASE CONTACT DE LA COAGULATIONTOBELEM G; SULTAN Y.1977; ACTUAL. HEMATOL.; FRA; DA. 1977; VOL. 11; PP. 122-125; BIBL. 7 REF.Article

POSSIBILITES THERAPEUTIQUES AU COURS DES TROUBLES SANGUINS LIES AUX INHIBITEURS ACQUIS DE LA COAGULATIONMAISONNEUVE P; SULTAN Y.1977; ACTUAL. HEMATOL.; FRA; DA. 1977; VOL. 11; PP. 132-138; BIBL. 8 REF.Article

INHIBITEURS IMMUNOLOGIQUES DU FACTEUR VIIISULTAN Y; HOMBURGER V.1976; REV. PRATICIEN; FR.; DA. 1976; VOL. 26; NO 29; PP. 2097-2107 (7P.); ABS. ANGL.; BIBL. 17 REF.Article

TRAITEMENT DE L'HEMOPHILIE AVEC INHIBITEUR IMMUNOLOGIQUE DU FACTEUR VIII PAR LES FRACTIONS COAGULANTES "ACTIVEES"SULTAN Y; BROUET JC.1975; NOUV. PRESSE MED.; FR.; DA. 1975; NO 36; PP. 2571-2574; ABS. ANGL.; BIBL. 8 REF.Article

High purity factor VIII concentrates for the treatment of HIV-positive patients with haemophiliaSULTAN, Y.Blood coagulation & fibrinolysis. 1995, Vol 6, pp S80-S81, issn 0957-5235, SUP2Conference Paper

PREDISPOSING FACTORS TO THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS: POSSIBLE RELATION TO ENDOTHELIAL CELL DAMAGEANGLES CANO E; SULTAN Y; CLAUVEL JP et al.1979; J. LAB. CLIN. MED.; USA; DA. 1979; VOL. 94; NO 2; PP. 312-323; BIBL. 91 REF.Article

PURIFICATION DE L'ACTIVATEUR DU PLASMINOGENE D'ORIGINE VASCULAIREANGLES CANO E; SULTAN Y; BERNARD J et al.1979; C.R. ACAD. SCI., D; FRA; DA. 1979; VOL. 289; NO 5; PP. 485-487; ABS. ENG; BIBL. 13 REF.Article

DETECTION OF HETEROZYGOTES IN BOTH PARENTS OF HOMOZYGOUS PATIENTS WITH VON WILLEBRAND'S DISEASE = DETECTION DES HETEROZYGOTES CHEZ LES 2PARENTS DE SUJETS HOMOZYGOTES ATTEINTS DE MALADIE DE WILLEBRANDSULTAN Y; SIMEON J; CAEN JP et al.1975; J. CLIN. PATHOL.; G.B.; DA. 1975; VOL. 28; NO 4; PP. 309-316; BIBL. 18REF.Article

COAGULATION INTRAVASCULAIRE DISSEMINEE ET FIBRINOLYSE AU COURS DES LEUCEMIES AIGUESBUNJEVACKI G; SULTAN Y; IZRAEL V et al.1978; NOUV. REV. FR. HEMATOL.; FRA; DA. 1978; VOL. 20; NO 4; PP. 575-584; ABS. ENG; BIBL. 29 REF.Article

CARBOHYDRATE DEFICIENCY OF THE FACTOR VIII/VON WILLEBRAND FACTOR PROTEIN IN VON WILLEBRAND'S DISEASE VARIANTGRALNICK HR; COLLER BS; SULTAN Y et al.1976; SCIENCE; U.S.A.; DA. 1976; VOL. 192; NO 4234; PP. 56-59; BIBL. 30 REF.Article

ELECTROPHORETIC HETEROGENEITY OF NORMAL FACTOR. VIII. VON WILLEBRAND PROTEIN, AND ABNORMAL ELECTROPHORETIC MOBILITY IN PATIENTS WITH VON WILLEBRAND'S DISEASE.SULTAN Y; SIMEON J; CAEN JP et al.1976; J. LAB. CLIN. MED.; U.S.A.; DA. 1976; VOL. 87; NO 2; PP. 185-197; BIBL. 17 REF.Article

STUDIES OF THE HUMAN FACTOR VIII/VON WILLEBRAND FACTOR PROTEIN. III. QUALITATIVE DEFECTS IN VON WILLEBRAND'S DISEASE.GRALNICK HR; COLLER BS; SULTAN Y et al.1975; J. CLIN. INVEST.; U.S.A.; DA. 1975; VOL. 56; NO 4; PP. 814-827; BIBL. 33 REF.Article

Tissue plasminogen activator in human megakaryocytes and platelets: immunocytochemical localization, immunoblotting and zymographic analysisJEANNEAU, C; SULTAN, Y.Thrombosis and haemostasis. 1988, Vol 59, Num 3, pp 529-534, issn 0340-6245Article

PLATELET FACTOR VIII-RELATED ANTIGEN: STUDIES IN VIVO AFTER TRANSFUSION IN PATIENTS WITH VON WILLEBRAND DISEASE.SULTAN Y; JEANNEAU C; LAMAZIERE J et al.1978; BLOOD; U.S.A.; DA. 1978; VOL. 51; NO 4; PP. 751-761; BIBL. 24 REF.Article